- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT07626359
Randomized Non-inferiority Within-Patient Trial of Density Gradient Processing of Sequential Ejaculates Versus Centrifugation-free Sperm Separation Device for ICSI in Men With Elevated Sperm DNA Fragmentation. (SE)
Elevated SDF can adversely impact fertilization, embryo development, and pregnancy outcomes in IVF-ICSI cycles. Two pragmatic strategies aim to reduce SDF on the day of ICSI: (i) obtaining a second ejaculate shortly after the first to reduce oxidative damage and transit time; and (ii) selecting sperm via centrifugation-free sperm separation device, which enriches for motile sperm with intact DNA. There are limited direct comparisons between these strategies; this study addresses that gap.
Studieöversikt
Status
Betingelser
Studietyp
Inskrivning (Beräknad)
Fas
- Inte tillämpbar
Kontakter och platser
Studiekontakt
- Namn: Shashank Sanagoudar, MS
- Telefonnummer: 91-8050406053
- E-post: drsanagoudar@gmail.com
Studera Kontakt Backup
- Namn: Sandro Esteves, PhD
- E-post: s.esteves@androfert.com.br
Studieorter
-
-
Bihar
-
Patna, Bihar, Indien, 800014
- Recruitment
-
-
Karnataka
-
Bangalore, Karnataka, Indien, 560078
- Indira IVF Hospital Limited
-
Underutredare:
- Shyam Gupta, MD
-
Kontakt:
- Shyam Gupta, MD
- E-post: centerhead.bangalore@indiraivf.in
-
-
Maharashtra
-
Bhāndup, Maharashtra, Indien
- Recruitment
-
Pune, Maharashtra, Indien
- Recruitment
-
-
National Capital Territory of Delhi
-
Delhi, National Capital Territory of Delhi, Indien
- Recruitment
-
-
Rajasthan
-
Jaipur, Rajasthan, Indien
- Recruitment
-
Udaipur, Rajasthan, Indien, 313001
- LAB
-
Kontakt:
- Vipin Chandra, DGO
- E-post: drvipinchandra@indiraivf.in
-
Kontakt:
- Shashank Sannagoudar, MS
- Telefonnummer: 8050406053
- E-post: drsanagoudar@gmail.com
-
-
Uttar Pradesh
-
Allahābād, Uttar Pradesh, Indien
- Recruitment
-
Lucknow, Uttar Pradesh, Indien
- Recruitment
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Beskrivning
Inclusion Criteria:
-
• Elevated SDF defined as DFI >20 %measured by the sperm chromatin dispersion (SCD) test performed in a participating center's andrology laboratory, using a harmonized protocol under standardized conditions after 2-3 days of ejaculatory abstinence, and within 90 days (≤3 months) prior to enrollment.
- Male partners 21-45 years;
- Female partners 21-35 years.
- Undergoing IVF/ICSI.
- No known genetic or chromosomal abnormalities.
- Minimum 4 MII oocyte patients shall be included
Exclusion Criteria:
- Azoospermia or severe oligoasthenozoospermia (<1 million motile sperm/mL).
- Significant systemic disease (e.g., uncontrolled diabetes, malignancy).
- History of a prior ICSI cycle with no embryo development.
- Relevant female factors: untreated adnexal pathology ,a history of a thin endometrium (<7 mm) following endometrium preparation for embryo transfer
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Behandling
- Tilldelning: Randomiserad
- Interventionsmodell: Crossover tilldelning
- Maskning: Ingen (Open Label)
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Experimentell: First Ejaculate
Processed using a centrifugation-free sperm sorting device |
Processed using density gradient centrifugation |
|
Experimentell: Second Ejaculate
The second ejaculate will be processed with two-layer density gradient centrifugation followed by standard washing. |
The second ejaculate will be processed with two-layer density gradient centrifugation followed by standard washing. |
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Ongoing Pregnancy Rate
Tidsram: 12 weeks of gestation
|
Ongoing pregnancy rate |
12 weeks of gestation
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Sperm motility and morphology after sperm sorting or second ejaculate collection.
Tidsram: At the day of ICSI
|
Sperm motility and morphology after sperm sorting or second ejaculate collection. |
At the day of ICSI
|
|
Blastocyst rate
Tidsram: Day 5&6 after ICSI
|
Blastocyst rate |
Day 5&6 after ICSI
|
|
Good Blastocyst rate
Tidsram: Day 5&6 after ICSI
|
Total number of good blast |
Day 5&6 after ICSI
|
|
Biochemical Pregnancy Rate
Tidsram: 2 weeks after embryo transfer
|
Biochemical Pregnancy Rate |
2 weeks after embryo transfer
|
|
Implantation Rate
Tidsram: 4-6 weeks after embryo transfer
|
An embryo implantation rate is the percentage of transferred embryos that successfully attach to the uterine lining and develop into a clinical pregnancy |
4-6 weeks after embryo transfer
|
|
Clinical Pregnancy Rate
Tidsram: 4-6 weeks after embryo transfer
|
measures the percentage of fertility treatment cycles (like IVF) that result in a pregnancy confirmed by an ultrasound showing a gestational sac or fetal heartbeat |
4-6 weeks after embryo transfer
|
|
First trimester Miscarriage Rate
Tidsram: Till 12 weeks after embryo transfer
|
Miscarriages are very common, occurring in about 10% to 20% of all known pregnancies. |
Till 12 weeks after embryo transfer
|
Samarbetspartners och utredare
Sponsor
Utredare
- Huvudutredare: Vipin Chandra, DGO, Indira IVF Hospital Limited
Publikationer och användbara länkar
Allmänna publikationer
- Humaidan P, Haahr T, Povlsen BB, Kofod L, Laursen RJ, Alsbjerg B, Elbaek HO, Esteves SC. The combined effect of lifestyle intervention and antioxidant therapy on sperm DNA fragmentation and seminal oxidative stress in IVF patients: a pilot study. Int Braz J Urol. 2022 Jan-Feb;48(1):131-156. doi: 10.1590/S1677-5538.IBJU.2021.0604.
- https://www.sciencedirect.com/science/article/pii/S0015028215018749
- Chandra V, Sanagoudar S, Shinde J, Shah N, Suwalka I, Esteves SC. Randomized non-inferiority within-patient trial of density gradient processing of sequential ejaculates versus centrifugation-free sperm separation device for ICSI in men with elevated sperm DNA fragmentation- study protocol. Front Urol. 2026 Sep 28;6:1913330. doi: 10.3389/fruro.2026.1913330. eCollection 2026.
Studieavstämningsdatum
Studera stora datum
Studiestart (Beräknad)
Primärt slutförande (Beräknad)
Avslutad studie (Beräknad)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Andra studie-ID-nummer
- IIHL-UDR/P/007_2025
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
IPD-planbeskrivning
Data will be shared on request
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .